A PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED CROSSOVER STUDY OF THE EFFICACY OF FESOTERODINE IN INCREASING URETHRAL PRESSURE IN STRESS URINARY INCONTINENCE PATIENTS • To determine whether fesoterodine increases urethral tone relative to placebo in SUI patients.

• Country None
• organs None
• Specialty None

OPEN LABEL EUROPEAN STUDY TO SUPPORT THE EARLY IDENTIFICATION OF PATIENTS WITH CHRONIC NEUROPATHIC LOW BACK PAIN IN PRIMARY CARE AND TO ASSESS THE EFFECTIVENESS AND TOLERABILITY OF PREGABALIN IN THIS POPULATION To raise awareness and enhance the diagnosis of patients with chronic low back pain(CLBP) with a neuropathic pain component who are refractory to standard analgesic therapy and/or one treatment for ne...

• Country None
• organs None
• Specialty None

A MULTICENTER, OPEN LABEL STUDY TO INVESTIGATE THE FEASIBILITY AND EFFICACY OF A SMOKING CESSATION PROGRAM WITH VARENICLINE IN PATIENTS UNDERGOING ELECTIVE SURGERY - Assess the feasibility of conducting a multicentre prospective trial involving smoking cessation treatment, pre-planned and scheduled surgery and collection of data on surgical site infections and...

• Country None
• organs None
• Specialty None

A Phase 2 study of the efficacy and safety of PH-797804 taken for 12 weeks in adults with COPD taking a background of salmeterol/fluticasone combination To evaluate the efficacy and safety/tolerability of 12 weeks administration of PH-797804 in adults with moderate to severe COPD (GOLD stage II/III) on a background of salmeterol xinafoate/fluticasone ...

• Country None
• organs None
• Specialty None

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS The primary objective is to demonstrate efficacy of CP-690,550 in inducing a clinical response in subjects with moderate-to-severe ulcerative colitis.

• Country None
• organs None
• Specialty None

A PHASE 2A, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE DOSE, 5-WAY CROSSOVER STUDY ASSESSING THE PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY PROFILES OF ORAL INHALED PF-03635659 IN PATIENTS WITH MODERATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE To estimate the bronchodilatory trough effect of 3 single dose levels of PF-03635659 delivered via the CRC749 inhaler device in moderate COPD subjects in order to select the lowest efficacious dose to...

• Country None
• organs None
• Specialty None

A 6 MONTH, PROSPECTIVE, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF FRAGMIN IN THE TREATMENT OF CHRONIC NEUROISCHAEMIC FOOT ULCERS IN DIABETIC PATIENTS Evaluate the effect of dalteparin compared to placebo on the healing of chronic neuroischaemic foot ulcers in diabetic patients with peripheral arterial occlusive disease (PAOD) and peripheral neuropa...

• Country None
• organs None
• Specialty None

A MULTICENTER, OPEN-LABEL, RANDOMIZED, TWO ARM CROSS-OVER STUDY ASSESSING DYAD (SUBJECT AND CAREGIVER) AND ADULT SUBJECT PERCEPTION OF CONVENIENCE AND PREFERENCE OF THE NEWLY DEVELOPED GENOTROPIN MARK VII PEN To evaluate the ease of use/convenience of the new Genotropin Mark VII pen compared to the current Genotropin Pen.

• Country None
• organs None
• Specialty None